Cargando…
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells
Recent studies provide compelling evidence that melanoma is initiated and maintained by a small population of malignant cells called cancer-initiating cells (CICs) that exhibit stem-cell-like properties. Observations that CICs have a distinct biology when compared to that of the bulk tumor cells and...
Autores principales: | Shidal, Chris, Al-Rayyan, Numan, Yaddanapudi, Kavitha, Davis, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356649/ https://www.ncbi.nlm.nih.gov/pubmed/27566591 http://dx.doi.org/10.18632/oncotarget.11554 |
Ejemplares similares
-
The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells
por: Shidal, Chris, et al.
Publicado: (2017) -
Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin
por: Devapatla, Bharat, et al.
Publicado: (2017) -
The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein
por: McConnell, Elizabeth J., et al.
Publicado: (2014) -
Recombinant production of the therapeutic peptide lunasin
por: Kyle, Stuart, et al.
Publicado: (2012) -
Potential Health Benefits Associated with Lunasin Concentration in Dietary Supplements and Lunasin-Enriched Soy Extract
por: Gonzalez de Mejia, Elvira, et al.
Publicado: (2021)